Zentek (ZTEK)
Develops intellectual property across graphite, graphene applications, and aptamer technologies.
Something off on this page? Send us feedback.
Develops and commercializes intellectual property across Albany Graphite, ZenGUARD™ graphene applications, and Triera aptamer technologies. Its current structure combines mineral-project development with materials and client-funded life-sciences R&D.
Three core platforms combine the Albany Graphite Project, ZenGUARD™ graphene applications, and Triera's aptamer technologies. Albany Graphite Corp., a wholly owned subsidiary, holds the Northern Ontario project. The company began directing resources toward graphene and related-application research in 2018.
ZenGUARD™ was developed and tested for PPE and HVAC applications. Triera Biosciences operates through a client-funded R&D/CRO model in which the company seeks to retain commercial rights to resulting innovations.
A January 2026 reset concentrated activities on these platforms, linking critical-mineral development, materials applications, and life-sciences R&D. The current structure remains centered on IP development and commercialization.
Company facts
Categories
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $12.0M · Total debt $1.4M · Total assets $22.4M · Shareholders' equity $18.3M
- Revenue
- $0
- Operating income
- −$1.6M
- Net income
- —
Reported in CAD, converted at the latest exchange rate
No dividends on record.
| Institutions24 holders · as of Mar 31, 2026 | 1.51% | 1.92M ADS | |
| Otherremainder | 98.49% | 124.70M ADS |
126.62M ADS as of Aug 21, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
The share count is from the company's Mar 2025 annual report; nothing newer is on file here.
The share count has not been confirmed by a second filing; stakes use it as it stands.
Some positions are filed in underlying shares, not receipts; the ratio is unknown, so no percentage.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Evidence |
|---|---|---|---|
Scotia Capital Inc.Institution | 0.67% | 845,665 ADS | 13Fas of Mar 31, 2026 |
Royal Bank of CanadaInstitution | 0.21% | 261,674 ADS | 13Fas of Mar 31, 2026 |
Signaturefd, LLCInstitution | 0.10% | 125,000 ADS | 13Fas of Mar 31, 2026 |
Citadel Advisors LLCInstitution | 0.09% | 113,679 ADS | 13Fas of Mar 31, 2026 |
CIBC World Market Inc.Institution | 0.07% | 89,884 ADS | 13Fas of Mar 31, 2026 |
| See all 24 → | |||
13F — a manager's quarterly holdings
Insider tradesForm 4
Nothing filed in the last 12 months.
- Nouveau Monde Graphite
Canadian natural-graphite supply chain from mine to processed material
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Zentek | $0.4920 | 0.00% | $62.3M | — | — | 818.8 | −95.4% |
| Nouveau Monde Graphite | $1.49 | +4.10% | $470.6M | — | — | — | — |